# 65% of Americans haven't considered GLP-1s for weight loss

Canonical page: https://data.verasight.io/health/64-of-americans-havent-considered-glp-1s-for-weight-loss/

> Indexed question in Health.

## Reading

Most Americans (65%) have not considered using a GLP-1 medication such as Ozempic or Wegovy to lose weight, according to a survey Verasight fielded from December 2025 into January 2026.

Another 12% have considered it briefly, 11% have seriously weighed it, and 12% are currently taking one.

## Topline

Have you considered using a GLP-1 medication to lose weight (e.g., Ozempic, Wegovy, etc)?

65% of Americans haven't considered GLP-1s for weight loss.

- No, I have not considered it: 65.0%
- Yes, I have considered it briefly: 12.1%
- Yes, I am currently using a GLP-1 medication: 12.1%
- Yes, I have seriously considered it: 10.8%

## Methodology

- Mode: Verasight panel recruited via random address-based sampling, random person-to-person text messaging, and dynamic online targeting
- Population: United States adults
- Field dates: 2025-12-22 → 2026-01-05
- Base (unweighted): 1,000
- Margin of error: +/- 3.1%
- Module: predictions
- Sponsor: Verasight
- Weight variable: weight for AI and predictions questions; weight_popculture for pop culture questions
- Weighting targets: age, race/ethnicity, sex, income, education, region, metropolitan status

## Source

- Canonical question URL: [https://reports.verasight.io/r/2026-predictions#use-of-glp-1-medications-for-weight-loss](https://reports.verasight.io/r/2026-predictions#use-of-glp-1-medications-for-weight-loss)

## Citation

2026 Predictions Survey #2025-183, fielded December 22, 2025-January 5, 2026, N=1,000 United States adults, +/- 3.1%.

Canonical question URL: [https://reports.verasight.io/r/2026-predictions#use-of-glp-1-medications-for-weight-loss](https://reports.verasight.io/r/2026-predictions#use-of-glp-1-medications-for-weight-loss)